Search

Author/Creator Geffriaud-Ricouard, Christine

1. Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease. (19th March 2021)

Authors:
Suzuki, Hiroyoshi; Castellano, Daniel; de Bono, Johann; Sternberg, Cora N; Fizazi, Karim; Tombal, Bertrand; Wülfing, Christian; Foster, Meredith C; Ozatilgan, Ayse; Geffriaud-Ricouard, Christine; de Wit, Ronald
Journal:
Japanese journal of clinical oncology
Issue:
Volume 51:Number 8(2021)
Page Start:
1287
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study. Issue 11 (November 2020)

Authors:
Fizazi, Karim; Kramer, Gero; Eymard, Jean-Christophe; Sternberg, Cora N; de Bono, Johann; Castellano, Daniel; Tombal, Bertrand; Wülfing, Christian; Liontos, Michael; Carles, Joan; Iacovelli, Roberto; Melichar, Bohuslav; Sverrisdóttir, Ásgerður; Theodore, Christine; Feyerabend, Susan; Helissey, Ca...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 11(2020)
Page Start:
1513
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search